Vigene Biosciences is planning a major expansion in Montgomery County, where it will add up to 245 new jobs by the end of 2025.
A global leader in gene therapy development, Vigene will expand into a new facility to accommodate industry demand for its gene and cellular therapy products. In addition to its existing headquarters, R&D and manufacturing locations in Rockville, the company will lease 52,000 square feet of manufacturing space at 14200 Shady Grove Road, bringing the total lab and manufacturing space of the company to 110,000 square feet. Vigene currently employs 125 workers in the county.
“Vigene serves over 4,000 clients worldwide, including our recently announced collaboration with Gaithersburg’s Altimmune to manufacture its single-dose intranasal vaccine candidate for COVID-19,” said Dr. Zairen Sun, Vigene’s president and CEO. “This new facility will allow us to support our customers as they move beyond clinical development into commercial scale manufacturing.”
“It is a testament to our state’s outstanding business climate and wealth of resources that we have seen so many life sciences companies expand and add thousands of new jobs in recent years,” said Governor Larry Hogan.